The first vaccines against COVID-19 have gone mostly to wealthier countries. Now, several middle-income countries are getting their shots. Many come from Chinese and Russian drugmakers. But critics note that these developers have not been forthcoming with data on their vaccines' safety and efficacy. VOA's Steve Baragona has more.
